An uncommon case of late thrombotic thrombocytopenic purpura (42 months) after autologous peripheral blood stem cell (PBSC) transplantation in a child

Bone Marrow Transplant. 1999 Apr;23(7):735-6. doi: 10.1038/sj.bmt.1701649.

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a serious complication following bone marrow transplantation (BMT). Therapeutic plasma exchange does not appear to be effective in its management in contrast to classical TTP. We report the case of a child with TTP 3 years after autologous PBSC transplantation, in whom remission was achieved by administration of cyclosporin A, after failure of plasmapheresis as primary treatment.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Purpura, Thrombotic Thrombocytopenic / etiology*
  • Time Factors